nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—ABCC2—epilepsy syndrome	0.346	1	CbGaD
Olmesartan—ABCC2—Levetiracetam—epilepsy syndrome	0.133	0.392	CbGbCtD
Olmesartan—ABCC2—Carbamazepine—epilepsy syndrome	0.0765	0.225	CbGbCtD
Olmesartan—ABCC2—Phenytoin—epilepsy syndrome	0.0686	0.202	CbGbCtD
Olmesartan—ABCC2—Phenobarbital—epilepsy syndrome	0.0612	0.18	CbGbCtD
Olmesartan—Irbesartan—JUN—epilepsy syndrome	0.00104	0.305	CrCbGaD
Olmesartan—Telmisartan—ABCC2—epilepsy syndrome	0.000491	0.144	CrCbGaD
Olmesartan—Telmisartan—ABCG2—epilepsy syndrome	0.000434	0.127	CrCbGaD
Olmesartan—Telmisartan—CYP2C19—epilepsy syndrome	0.000342	0.1	CrCbGaD
Olmesartan—Irbesartan—CYP2D6—epilepsy syndrome	0.000204	0.0599	CrCbGaD
Olmesartan—Valsartan—ALB—epilepsy syndrome	0.000201	0.0591	CrCbGaD
Olmesartan—Telmisartan—ABCB1—epilepsy syndrome	0.000181	0.053	CrCbGaD
Olmesartan—Losartan—CYP2C19—epilepsy syndrome	0.000177	0.052	CrCbGaD
Olmesartan—Candesartan—ABCB1—epilepsy syndrome	0.000146	0.0428	CrCbGaD
Olmesartan—Losartan—ALB—epilepsy syndrome	9.84e-05	0.0289	CrCbGaD
Olmesartan—Losartan—ABCB1—epilepsy syndrome	9.39e-05	0.0275	CrCbGaD
Olmesartan—Asthenia—Phenytoin—epilepsy syndrome	6.6e-05	0.000307	CcSEcCtD
Olmesartan—Nausea—Midazolam—epilepsy syndrome	6.59e-05	0.000307	CcSEcCtD
Olmesartan—Muscle spasms—Gabapentin—epilepsy syndrome	6.59e-05	0.000307	CcSEcCtD
Olmesartan—Tachycardia—Valproic Acid—epilepsy syndrome	6.58e-05	0.000306	CcSEcCtD
Olmesartan—Diarrhoea—Zonisamide—epilepsy syndrome	6.58e-05	0.000306	CcSEcCtD
Olmesartan—Pharyngitis—Topiramate—epilepsy syndrome	6.57e-05	0.000306	CcSEcCtD
Olmesartan—Loss of consciousness—Pregabalin—epilepsy syndrome	6.57e-05	0.000306	CcSEcCtD
Olmesartan—Asthenia—Oxcarbazepine—epilepsy syndrome	6.57e-05	0.000306	CcSEcCtD
Olmesartan—Pruritus—Clonazepam—epilepsy syndrome	6.55e-05	0.000305	CcSEcCtD
Olmesartan—Vomiting—Vigabatrin—epilepsy syndrome	6.55e-05	0.000305	CcSEcCtD
Olmesartan—Skin disorder—Valproic Acid—epilepsy syndrome	6.55e-05	0.000305	CcSEcCtD
Olmesartan—Urinary tract disorder—Topiramate—epilepsy syndrome	6.54e-05	0.000304	CcSEcCtD
Olmesartan—Oedema peripheral—Topiramate—epilepsy syndrome	6.52e-05	0.000304	CcSEcCtD
Olmesartan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.52e-05	0.000304	CcSEcCtD
Olmesartan—Cough—Pregabalin—epilepsy syndrome	6.52e-05	0.000304	CcSEcCtD
Olmesartan—Pruritus—Phenytoin—epilepsy syndrome	6.51e-05	0.000303	CcSEcCtD
Olmesartan—Connective tissue disorder—Topiramate—epilepsy syndrome	6.51e-05	0.000303	CcSEcCtD
Olmesartan—Nausea—Levetiracetam—epilepsy syndrome	6.51e-05	0.000303	CcSEcCtD
Olmesartan—Rash—Vigabatrin—epilepsy syndrome	6.5e-05	0.000303	CcSEcCtD
Olmesartan—Dizziness—Felbamate—epilepsy syndrome	6.49e-05	0.000302	CcSEcCtD
Olmesartan—Dermatitis—Vigabatrin—epilepsy syndrome	6.49e-05	0.000302	CcSEcCtD
Olmesartan—Urethral disorder—Topiramate—epilepsy syndrome	6.49e-05	0.000302	CcSEcCtD
Olmesartan—Pruritus—Oxcarbazepine—epilepsy syndrome	6.48e-05	0.000301	CcSEcCtD
Olmesartan—Vision blurred—Gabapentin—epilepsy syndrome	6.46e-05	0.000301	CcSEcCtD
Olmesartan—Headache—Vigabatrin—epilepsy syndrome	6.46e-05	0.000301	CcSEcCtD
Olmesartan—Vomiting—Diazepam—epilepsy syndrome	6.45e-05	0.0003	CcSEcCtD
Olmesartan—Anorexia—Valproic Acid—epilepsy syndrome	6.43e-05	0.000299	CcSEcCtD
Olmesartan—Rash—Diazepam—epilepsy syndrome	6.4e-05	0.000298	CcSEcCtD
Olmesartan—Dermatitis—Diazepam—epilepsy syndrome	6.39e-05	0.000298	CcSEcCtD
Olmesartan—Myalgia—Pregabalin—epilepsy syndrome	6.36e-05	0.000296	CcSEcCtD
Olmesartan—Chest pain—Pregabalin—epilepsy syndrome	6.36e-05	0.000296	CcSEcCtD
Olmesartan—Arthralgia—Pregabalin—epilepsy syndrome	6.36e-05	0.000296	CcSEcCtD
Olmesartan—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.36e-05	0.000296	CcSEcCtD
Olmesartan—Dizziness—Zonisamide—epilepsy syndrome	6.36e-05	0.000296	CcSEcCtD
Olmesartan—Headache—Diazepam—epilepsy syndrome	6.36e-05	0.000296	CcSEcCtD
Olmesartan—Anxiety—Pregabalin—epilepsy syndrome	6.34e-05	0.000295	CcSEcCtD
Olmesartan—Diarrhoea—Clonazepam—epilepsy syndrome	6.34e-05	0.000295	CcSEcCtD
Olmesartan—Anaemia—Gabapentin—epilepsy syndrome	6.33e-05	0.000295	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.32e-05	0.000294	CcSEcCtD
Olmesartan—Hypotension—Valproic Acid—epilepsy syndrome	6.3e-05	0.000293	CcSEcCtD
Olmesartan—Asthenia—Carbamazepine—epilepsy syndrome	6.3e-05	0.000293	CcSEcCtD
Olmesartan—Agitation—Gabapentin—epilepsy syndrome	6.3e-05	0.000293	CcSEcCtD
Olmesartan—Diarrhoea—Phenytoin—epilepsy syndrome	6.3e-05	0.000293	CcSEcCtD
Olmesartan—Discomfort—Pregabalin—epilepsy syndrome	6.29e-05	0.000293	CcSEcCtD
Olmesartan—Nausea—Fosphenytoin—epilepsy syndrome	6.28e-05	0.000292	CcSEcCtD
Olmesartan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.26e-05	0.000292	CcSEcCtD
Olmesartan—Angioedema—Gabapentin—epilepsy syndrome	6.26e-05	0.000291	CcSEcCtD
Olmesartan—Vomiting—Felbamate—epilepsy syndrome	6.24e-05	0.000291	CcSEcCtD
Olmesartan—Pruritus—Carbamazepine—epilepsy syndrome	6.21e-05	0.000289	CcSEcCtD
Olmesartan—Rash—Felbamate—epilepsy syndrome	6.19e-05	0.000288	CcSEcCtD
Olmesartan—Dermatitis—Felbamate—epilepsy syndrome	6.19e-05	0.000288	CcSEcCtD
Olmesartan—Malaise—Gabapentin—epilepsy syndrome	6.18e-05	0.000288	CcSEcCtD
Olmesartan—Vertigo—Gabapentin—epilepsy syndrome	6.16e-05	0.000287	CcSEcCtD
Olmesartan—Headache—Felbamate—epilepsy syndrome	6.15e-05	0.000286	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.15e-05	0.000286	CcSEcCtD
Olmesartan—Syncope—Gabapentin—epilepsy syndrome	6.15e-05	0.000286	CcSEcCtD
Olmesartan—Leukopenia—Gabapentin—epilepsy syndrome	6.13e-05	0.000286	CcSEcCtD
Olmesartan—Dizziness—Clonazepam—epilepsy syndrome	6.13e-05	0.000285	CcSEcCtD
Olmesartan—Nausea—Vigabatrin—epilepsy syndrome	6.12e-05	0.000285	CcSEcCtD
Olmesartan—Vomiting—Zonisamide—epilepsy syndrome	6.11e-05	0.000285	CcSEcCtD
Olmesartan—Insomnia—Valproic Acid—epilepsy syndrome	6.1e-05	0.000284	CcSEcCtD
Olmesartan—Oedema—Pregabalin—epilepsy syndrome	6.1e-05	0.000284	CcSEcCtD
Olmesartan—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.1e-05	0.000284	CcSEcCtD
Olmesartan—Asthenia—Lamotrigine—epilepsy syndrome	6.09e-05	0.000284	CcSEcCtD
Olmesartan—Dizziness—Phenytoin—epilepsy syndrome	6.09e-05	0.000283	CcSEcCtD
Olmesartan—Rash—Zonisamide—epilepsy syndrome	6.06e-05	0.000282	CcSEcCtD
Olmesartan—Infection—Pregabalin—epilepsy syndrome	6.06e-05	0.000282	CcSEcCtD
Olmesartan—Palpitations—Gabapentin—epilepsy syndrome	6.06e-05	0.000282	CcSEcCtD
Olmesartan—Dermatitis—Zonisamide—epilepsy syndrome	6.06e-05	0.000282	CcSEcCtD
Olmesartan—Dizziness—Oxcarbazepine—epilepsy syndrome	6.05e-05	0.000282	CcSEcCtD
Olmesartan—Nausea—Diazepam—epilepsy syndrome	6.03e-05	0.000281	CcSEcCtD
Olmesartan—Loss of consciousness—Gabapentin—epilepsy syndrome	6.02e-05	0.00028	CcSEcCtD
Olmesartan—Headache—Zonisamide—epilepsy syndrome	6.02e-05	0.00028	CcSEcCtD
Olmesartan—Diarrhoea—Carbamazepine—epilepsy syndrome	6.01e-05	0.00028	CcSEcCtD
Olmesartan—Angiopathy—Topiramate—epilepsy syndrome	6.01e-05	0.00028	CcSEcCtD
Olmesartan—Pruritus—Lamotrigine—epilepsy syndrome	6.01e-05	0.00028	CcSEcCtD
Olmesartan—Shock—Pregabalin—epilepsy syndrome	6e-05	0.000279	CcSEcCtD
Olmesartan—Nervous system disorder—Pregabalin—epilepsy syndrome	5.98e-05	0.000278	CcSEcCtD
Olmesartan—Cough—Gabapentin—epilepsy syndrome	5.98e-05	0.000278	CcSEcCtD
Olmesartan—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.97e-05	0.000278	CcSEcCtD
Olmesartan—Mediastinal disorder—Topiramate—epilepsy syndrome	5.97e-05	0.000278	CcSEcCtD
Olmesartan—Tachycardia—Pregabalin—epilepsy syndrome	5.95e-05	0.000277	CcSEcCtD
Olmesartan—Dyspepsia—Valproic Acid—epilepsy syndrome	5.94e-05	0.000276	CcSEcCtD
Olmesartan—Skin disorder—Pregabalin—epilepsy syndrome	5.92e-05	0.000276	CcSEcCtD
Olmesartan—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.9e-05	0.000274	CcSEcCtD
Olmesartan—Vomiting—Clonazepam—epilepsy syndrome	5.89e-05	0.000274	CcSEcCtD
Olmesartan—Decreased appetite—Valproic Acid—epilepsy syndrome	5.86e-05	0.000273	CcSEcCtD
Olmesartan—Alopecia—Topiramate—epilepsy syndrome	5.85e-05	0.000272	CcSEcCtD
Olmesartan—Vomiting—Phenytoin—epilepsy syndrome	5.85e-05	0.000272	CcSEcCtD
Olmesartan—Rash—Clonazepam—epilepsy syndrome	5.84e-05	0.000272	CcSEcCtD
Olmesartan—Dermatitis—Clonazepam—epilepsy syndrome	5.84e-05	0.000272	CcSEcCtD
Olmesartan—Chest pain—Gabapentin—epilepsy syndrome	5.83e-05	0.000272	CcSEcCtD
Olmesartan—Myalgia—Gabapentin—epilepsy syndrome	5.83e-05	0.000272	CcSEcCtD
Olmesartan—Arthralgia—Gabapentin—epilepsy syndrome	5.83e-05	0.000272	CcSEcCtD
Olmesartan—Nausea—Felbamate—epilepsy syndrome	5.83e-05	0.000272	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.82e-05	0.000271	CcSEcCtD
Olmesartan—Vomiting—Oxcarbazepine—epilepsy syndrome	5.82e-05	0.000271	CcSEcCtD
Olmesartan—Fatigue—Valproic Acid—epilepsy syndrome	5.82e-05	0.000271	CcSEcCtD
Olmesartan—Anxiety—Gabapentin—epilepsy syndrome	5.81e-05	0.000271	CcSEcCtD
Olmesartan—Anorexia—Pregabalin—epilepsy syndrome	5.81e-05	0.000271	CcSEcCtD
Olmesartan—Dizziness—Carbamazepine—epilepsy syndrome	5.81e-05	0.00027	CcSEcCtD
Olmesartan—Diarrhoea—Lamotrigine—epilepsy syndrome	5.81e-05	0.00027	CcSEcCtD
Olmesartan—Headache—Clonazepam—epilepsy syndrome	5.8e-05	0.00027	CcSEcCtD
Olmesartan—Rash—Phenytoin—epilepsy syndrome	5.8e-05	0.00027	CcSEcCtD
Olmesartan—Mental disorder—Topiramate—epilepsy syndrome	5.8e-05	0.00027	CcSEcCtD
Olmesartan—Dermatitis—Phenytoin—epilepsy syndrome	5.8e-05	0.00027	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.79e-05	0.00027	CcSEcCtD
Olmesartan—Rash—Oxcarbazepine—epilepsy syndrome	5.77e-05	0.000269	CcSEcCtD
Olmesartan—Pain—Valproic Acid—epilepsy syndrome	5.77e-05	0.000269	CcSEcCtD
Olmesartan—Constipation—Valproic Acid—epilepsy syndrome	5.77e-05	0.000269	CcSEcCtD
Olmesartan—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.77e-05	0.000268	CcSEcCtD
Olmesartan—Headache—Phenytoin—epilepsy syndrome	5.77e-05	0.000268	CcSEcCtD
Olmesartan—Malnutrition—Topiramate—epilepsy syndrome	5.77e-05	0.000268	CcSEcCtD
Olmesartan—Discomfort—Gabapentin—epilepsy syndrome	5.76e-05	0.000268	CcSEcCtD
Olmesartan—Headache—Oxcarbazepine—epilepsy syndrome	5.73e-05	0.000267	CcSEcCtD
Olmesartan—Nausea—Zonisamide—epilepsy syndrome	5.71e-05	0.000266	CcSEcCtD
Olmesartan—Hypotension—Pregabalin—epilepsy syndrome	5.7e-05	0.000265	CcSEcCtD
Olmesartan—Dizziness—Lamotrigine—epilepsy syndrome	5.61e-05	0.000261	CcSEcCtD
Olmesartan—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.59e-05	0.00026	CcSEcCtD
Olmesartan—Oedema—Gabapentin—epilepsy syndrome	5.59e-05	0.00026	CcSEcCtD
Olmesartan—Vomiting—Carbamazepine—epilepsy syndrome	5.59e-05	0.00026	CcSEcCtD
Olmesartan—Back pain—Topiramate—epilepsy syndrome	5.58e-05	0.00026	CcSEcCtD
Olmesartan—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.56e-05	0.000259	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.56e-05	0.000259	CcSEcCtD
Olmesartan—Infection—Gabapentin—epilepsy syndrome	5.56e-05	0.000259	CcSEcCtD
Olmesartan—Muscle spasms—Topiramate—epilepsy syndrome	5.54e-05	0.000258	CcSEcCtD
Olmesartan—Rash—Carbamazepine—epilepsy syndrome	5.54e-05	0.000258	CcSEcCtD
Olmesartan—Dermatitis—Carbamazepine—epilepsy syndrome	5.53e-05	0.000258	CcSEcCtD
Olmesartan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.52e-05	0.000257	CcSEcCtD
Olmesartan—Insomnia—Pregabalin—epilepsy syndrome	5.52e-05	0.000257	CcSEcCtD
Olmesartan—Nausea—Clonazepam—epilepsy syndrome	5.5e-05	0.000256	CcSEcCtD
Olmesartan—Headache—Carbamazepine—epilepsy syndrome	5.5e-05	0.000256	CcSEcCtD
Olmesartan—Shock—Gabapentin—epilepsy syndrome	5.5e-05	0.000256	CcSEcCtD
Olmesartan—Nervous system disorder—Gabapentin—epilepsy syndrome	5.48e-05	0.000255	CcSEcCtD
Olmesartan—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.48e-05	0.000255	CcSEcCtD
Olmesartan—Nausea—Phenytoin—epilepsy syndrome	5.47e-05	0.000254	CcSEcCtD
Olmesartan—Tachycardia—Gabapentin—epilepsy syndrome	5.46e-05	0.000254	CcSEcCtD
Olmesartan—Nausea—Oxcarbazepine—epilepsy syndrome	5.44e-05	0.000253	CcSEcCtD
Olmesartan—Vision blurred—Topiramate—epilepsy syndrome	5.43e-05	0.000253	CcSEcCtD
Olmesartan—Skin disorder—Gabapentin—epilepsy syndrome	5.43e-05	0.000253	CcSEcCtD
Olmesartan—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.41e-05	0.000252	CcSEcCtD
Olmesartan—Vomiting—Lamotrigine—epilepsy syndrome	5.4e-05	0.000251	CcSEcCtD
Olmesartan—Urticaria—Valproic Acid—epilepsy syndrome	5.36e-05	0.000249	CcSEcCtD
Olmesartan—Rash—Lamotrigine—epilepsy syndrome	5.35e-05	0.000249	CcSEcCtD
Olmesartan—Ill-defined disorder—Topiramate—epilepsy syndrome	5.35e-05	0.000249	CcSEcCtD
Olmesartan—Dermatitis—Lamotrigine—epilepsy syndrome	5.35e-05	0.000249	CcSEcCtD
Olmesartan—Abdominal pain—Valproic Acid—epilepsy syndrome	5.33e-05	0.000248	CcSEcCtD
Olmesartan—Body temperature increased—Valproic Acid—epilepsy syndrome	5.33e-05	0.000248	CcSEcCtD
Olmesartan—Anorexia—Gabapentin—epilepsy syndrome	5.33e-05	0.000248	CcSEcCtD
Olmesartan—Anaemia—Topiramate—epilepsy syndrome	5.33e-05	0.000248	CcSEcCtD
Olmesartan—Headache—Lamotrigine—epilepsy syndrome	5.32e-05	0.000248	CcSEcCtD
Olmesartan—Decreased appetite—Pregabalin—epilepsy syndrome	5.3e-05	0.000247	CcSEcCtD
Olmesartan—Agitation—Topiramate—epilepsy syndrome	5.3e-05	0.000247	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.27e-05	0.000245	CcSEcCtD
Olmesartan—Fatigue—Pregabalin—epilepsy syndrome	5.26e-05	0.000245	CcSEcCtD
Olmesartan—Hypotension—Gabapentin—epilepsy syndrome	5.23e-05	0.000243	CcSEcCtD
Olmesartan—Nausea—Carbamazepine—epilepsy syndrome	5.22e-05	0.000243	CcSEcCtD
Olmesartan—Constipation—Pregabalin—epilepsy syndrome	5.22e-05	0.000243	CcSEcCtD
Olmesartan—Pain—Pregabalin—epilepsy syndrome	5.22e-05	0.000243	CcSEcCtD
Olmesartan—Malaise—Topiramate—epilepsy syndrome	5.2e-05	0.000242	CcSEcCtD
Olmesartan—Vertigo—Topiramate—epilepsy syndrome	5.18e-05	0.000241	CcSEcCtD
Olmesartan—Syncope—Topiramate—epilepsy syndrome	5.17e-05	0.000241	CcSEcCtD
Olmesartan—Leukopenia—Topiramate—epilepsy syndrome	5.16e-05	0.00024	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.1e-05	0.000237	CcSEcCtD
Olmesartan—Palpitations—Topiramate—epilepsy syndrome	5.09e-05	0.000237	CcSEcCtD
Olmesartan—Loss of consciousness—Topiramate—epilepsy syndrome	5.07e-05	0.000236	CcSEcCtD
Olmesartan—Insomnia—Gabapentin—epilepsy syndrome	5.06e-05	0.000235	CcSEcCtD
Olmesartan—Nausea—Lamotrigine—epilepsy syndrome	5.04e-05	0.000235	CcSEcCtD
Olmesartan—Cough—Topiramate—epilepsy syndrome	5.03e-05	0.000234	CcSEcCtD
Olmesartan—Feeling abnormal—Pregabalin—epilepsy syndrome	5.03e-05	0.000234	CcSEcCtD
Olmesartan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.99e-05	0.000232	CcSEcCtD
Olmesartan—Dyspepsia—Gabapentin—epilepsy syndrome	4.92e-05	0.000229	CcSEcCtD
Olmesartan—Myalgia—Topiramate—epilepsy syndrome	4.91e-05	0.000228	CcSEcCtD
Olmesartan—Chest pain—Topiramate—epilepsy syndrome	4.91e-05	0.000228	CcSEcCtD
Olmesartan—Arthralgia—Topiramate—epilepsy syndrome	4.91e-05	0.000228	CcSEcCtD
Olmesartan—Anxiety—Topiramate—epilepsy syndrome	4.89e-05	0.000228	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.87e-05	0.000227	CcSEcCtD
Olmesartan—Decreased appetite—Gabapentin—epilepsy syndrome	4.86e-05	0.000226	CcSEcCtD
Olmesartan—Discomfort—Topiramate—epilepsy syndrome	4.85e-05	0.000226	CcSEcCtD
Olmesartan—Urticaria—Pregabalin—epilepsy syndrome	4.85e-05	0.000226	CcSEcCtD
Olmesartan—Asthenia—Valproic Acid—epilepsy syndrome	4.84e-05	0.000225	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.83e-05	0.000225	CcSEcCtD
Olmesartan—Fatigue—Gabapentin—epilepsy syndrome	4.82e-05	0.000224	CcSEcCtD
Olmesartan—Body temperature increased—Pregabalin—epilepsy syndrome	4.82e-05	0.000224	CcSEcCtD
Olmesartan—Abdominal pain—Pregabalin—epilepsy syndrome	4.82e-05	0.000224	CcSEcCtD
Olmesartan—Constipation—Gabapentin—epilepsy syndrome	4.78e-05	0.000223	CcSEcCtD
Olmesartan—Pain—Gabapentin—epilepsy syndrome	4.78e-05	0.000223	CcSEcCtD
Olmesartan—Pruritus—Valproic Acid—epilepsy syndrome	4.77e-05	0.000222	CcSEcCtD
Olmesartan—Oedema—Topiramate—epilepsy syndrome	4.71e-05	0.000219	CcSEcCtD
Olmesartan—Infection—Topiramate—epilepsy syndrome	4.67e-05	0.000218	CcSEcCtD
Olmesartan—Shock—Topiramate—epilepsy syndrome	4.63e-05	0.000215	CcSEcCtD
Olmesartan—Diarrhoea—Valproic Acid—epilepsy syndrome	4.62e-05	0.000215	CcSEcCtD
Olmesartan—Nervous system disorder—Topiramate—epilepsy syndrome	4.61e-05	0.000215	CcSEcCtD
Olmesartan—Feeling abnormal—Gabapentin—epilepsy syndrome	4.61e-05	0.000215	CcSEcCtD
Olmesartan—Thrombocytopenia—Topiramate—epilepsy syndrome	4.61e-05	0.000214	CcSEcCtD
Olmesartan—Tachycardia—Topiramate—epilepsy syndrome	4.59e-05	0.000214	CcSEcCtD
Olmesartan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.57e-05	0.000213	CcSEcCtD
Olmesartan—Skin disorder—Topiramate—epilepsy syndrome	4.57e-05	0.000213	CcSEcCtD
Olmesartan—Hyperhidrosis—Topiramate—epilepsy syndrome	4.55e-05	0.000212	CcSEcCtD
Olmesartan—Anorexia—Topiramate—epilepsy syndrome	4.49e-05	0.000209	CcSEcCtD
Olmesartan—Dizziness—Valproic Acid—epilepsy syndrome	4.46e-05	0.000208	CcSEcCtD
Olmesartan—Urticaria—Gabapentin—epilepsy syndrome	4.44e-05	0.000207	CcSEcCtD
Olmesartan—Abdominal pain—Gabapentin—epilepsy syndrome	4.42e-05	0.000206	CcSEcCtD
Olmesartan—Body temperature increased—Gabapentin—epilepsy syndrome	4.42e-05	0.000206	CcSEcCtD
Olmesartan—Hypotension—Topiramate—epilepsy syndrome	4.4e-05	0.000205	CcSEcCtD
Olmesartan—Asthenia—Pregabalin—epilepsy syndrome	4.38e-05	0.000204	CcSEcCtD
Olmesartan—Pruritus—Pregabalin—epilepsy syndrome	4.32e-05	0.000201	CcSEcCtD
Olmesartan—Vomiting—Valproic Acid—epilepsy syndrome	4.29e-05	0.0002	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.29e-05	0.0002	CcSEcCtD
Olmesartan—Insomnia—Topiramate—epilepsy syndrome	4.26e-05	0.000198	CcSEcCtD
Olmesartan—Rash—Valproic Acid—epilepsy syndrome	4.25e-05	0.000198	CcSEcCtD
Olmesartan—Dermatitis—Valproic Acid—epilepsy syndrome	4.25e-05	0.000198	CcSEcCtD
Olmesartan—Headache—Valproic Acid—epilepsy syndrome	4.23e-05	0.000197	CcSEcCtD
Olmesartan—Diarrhoea—Pregabalin—epilepsy syndrome	4.17e-05	0.000194	CcSEcCtD
Olmesartan—Dyspepsia—Topiramate—epilepsy syndrome	4.14e-05	0.000193	CcSEcCtD
Olmesartan—Decreased appetite—Topiramate—epilepsy syndrome	4.09e-05	0.00019	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.06e-05	0.000189	CcSEcCtD
Olmesartan—Fatigue—Topiramate—epilepsy syndrome	4.06e-05	0.000189	CcSEcCtD
Olmesartan—Dizziness—Pregabalin—epilepsy syndrome	4.03e-05	0.000188	CcSEcCtD
Olmesartan—Constipation—Topiramate—epilepsy syndrome	4.02e-05	0.000187	CcSEcCtD
Olmesartan—Pain—Topiramate—epilepsy syndrome	4.02e-05	0.000187	CcSEcCtD
Olmesartan—Asthenia—Gabapentin—epilepsy syndrome	4.01e-05	0.000187	CcSEcCtD
Olmesartan—Nausea—Valproic Acid—epilepsy syndrome	4.01e-05	0.000187	CcSEcCtD
Olmesartan—Pruritus—Gabapentin—epilepsy syndrome	3.96e-05	0.000184	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—QDPR—epilepsy syndrome	3.94e-05	0.000408	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA4—epilepsy syndrome	3.94e-05	0.000408	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.94e-05	0.000408	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	3.92e-05	0.000406	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CRH—epilepsy syndrome	3.92e-05	0.000406	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—OXT—epilepsy syndrome	3.92e-05	0.000406	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.9e-05	0.000404	CbGpPWpGaD
Olmesartan—Vomiting—Pregabalin—epilepsy syndrome	3.88e-05	0.000181	CcSEcCtD
Olmesartan—Feeling abnormal—Topiramate—epilepsy syndrome	3.88e-05	0.00018	CcSEcCtD
Olmesartan—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.85e-05	0.000179	CcSEcCtD
Olmesartan—Rash—Pregabalin—epilepsy syndrome	3.85e-05	0.000179	CcSEcCtD
Olmesartan—Dermatitis—Pregabalin—epilepsy syndrome	3.84e-05	0.000179	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.83e-05	0.000397	CbGpPWpGaD
Olmesartan—Diarrhoea—Gabapentin—epilepsy syndrome	3.83e-05	0.000178	CcSEcCtD
Olmesartan—Headache—Pregabalin—epilepsy syndrome	3.82e-05	0.000178	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CCR3—epilepsy syndrome	3.79e-05	0.000392	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CACNA1A—epilepsy syndrome	3.78e-05	0.000391	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALDH7A1—epilepsy syndrome	3.78e-05	0.000391	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—AGT—epilepsy syndrome	3.75e-05	0.000389	CbGpPWpGaD
Olmesartan—Urticaria—Topiramate—epilepsy syndrome	3.74e-05	0.000174	CcSEcCtD
Olmesartan—Abdominal pain—Topiramate—epilepsy syndrome	3.72e-05	0.000173	CcSEcCtD
Olmesartan—Body temperature increased—Topiramate—epilepsy syndrome	3.72e-05	0.000173	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—COX3—epilepsy syndrome	3.7e-05	0.000384	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ST3GAL3—epilepsy syndrome	3.7e-05	0.000383	CbGpPWpGaD
Olmesartan—Dizziness—Gabapentin—epilepsy syndrome	3.7e-05	0.000172	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—NPY—epilepsy syndrome	3.69e-05	0.000382	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.66e-05	0.000379	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADSL—epilepsy syndrome	3.62e-05	0.000375	CbGpPWpGaD
Olmesartan—Nausea—Pregabalin—epilepsy syndrome	3.62e-05	0.000169	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—SSTR3—epilepsy syndrome	3.62e-05	0.000375	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.57e-05	0.000369	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—OXT—epilepsy syndrome	3.56e-05	0.000369	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CRH—epilepsy syndrome	3.56e-05	0.000369	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL3—epilepsy syndrome	3.56e-05	0.000369	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL2—epilepsy syndrome	3.56e-05	0.000369	CbGpPWpGaD
Olmesartan—Vomiting—Gabapentin—epilepsy syndrome	3.56e-05	0.000166	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GLUL—epilepsy syndrome	3.55e-05	0.000368	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR2—epilepsy syndrome	3.55e-05	0.000367	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—SST—epilepsy syndrome	3.55e-05	0.000367	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.54e-05	0.000367	CbGpPWpGaD
Olmesartan—Rash—Gabapentin—epilepsy syndrome	3.53e-05	0.000164	CcSEcCtD
Olmesartan—Dermatitis—Gabapentin—epilepsy syndrome	3.52e-05	0.000164	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—SLCO1A2—epilepsy syndrome	3.51e-05	0.000364	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CACNA2D2—epilepsy syndrome	3.51e-05	0.000364	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—KCNB1—epilepsy syndrome	3.51e-05	0.000364	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PFKL—epilepsy syndrome	3.51e-05	0.000364	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC6A8—epilepsy syndrome	3.51e-05	0.000364	CbGpPWpGaD
Olmesartan—Headache—Gabapentin—epilepsy syndrome	3.5e-05	0.000163	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—CACNA1D—epilepsy syndrome	3.49e-05	0.000361	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.48e-05	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.47e-05	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPY2R—epilepsy syndrome	3.47e-05	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR9—epilepsy syndrome	3.47e-05	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SSTR1—epilepsy syndrome	3.47e-05	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR8—epilepsy syndrome	3.47e-05	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.47e-05	0.000359	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.43e-05	0.000355	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.41e-05	0.000353	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRM3—epilepsy syndrome	3.41e-05	0.000353	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRM4—epilepsy syndrome	3.41e-05	0.000353	CbGpPWpGaD
Olmesartan—Asthenia—Topiramate—epilepsy syndrome	3.38e-05	0.000157	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.35e-05	0.000347	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DUSP4—epilepsy syndrome	3.34e-05	0.000346	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SSTR2—epilepsy syndrome	3.34e-05	0.000346	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.33e-05	0.000345	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.33e-05	0.000345	CbGpPWpGaD
Olmesartan—Pruritus—Topiramate—epilepsy syndrome	3.33e-05	0.000155	CcSEcCtD
Olmesartan—Nausea—Gabapentin—epilepsy syndrome	3.32e-05	0.000155	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.27e-05	0.000339	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.26e-05	0.000338	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TXNRD1—epilepsy syndrome	3.26e-05	0.000338	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.26e-05	0.000338	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.24e-05	0.000336	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRM8—epilepsy syndrome	3.23e-05	0.000334	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PGF—epilepsy syndrome	3.23e-05	0.000334	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—SST—epilepsy syndrome	3.22e-05	0.000333	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR2—epilepsy syndrome	3.22e-05	0.000333	CbGpPWpGaD
Olmesartan—Diarrhoea—Topiramate—epilepsy syndrome	3.22e-05	0.00015	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.21e-05	0.000333	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NEU1—epilepsy syndrome	3.21e-05	0.000333	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UPB1—epilepsy syndrome	3.21e-05	0.000333	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ATIC—epilepsy syndrome	3.21e-05	0.000333	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.19e-05	0.000331	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AQP1—epilepsy syndrome	3.17e-05	0.000328	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—POMC—epilepsy syndrome	3.16e-05	0.000327	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.15e-05	0.000326	CbGpPWpGaD
Olmesartan—Dizziness—Topiramate—epilepsy syndrome	3.11e-05	0.000145	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.11e-05	0.000322	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL2—epilepsy syndrome	3.09e-05	0.00032	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD17B4—epilepsy syndrome	3.09e-05	0.00032	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GNAO1—epilepsy syndrome	3.08e-05	0.000319	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OPRD1—epilepsy syndrome	3.08e-05	0.000319	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.04e-05	0.000315	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.04e-05	0.000315	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.03e-05	0.000314	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.03e-05	0.000314	CbGpPWpGaD
Olmesartan—Vomiting—Topiramate—epilepsy syndrome	2.99e-05	0.000139	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—PPP1R3C—epilepsy syndrome	2.99e-05	0.000309	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GBE1—epilepsy syndrome	2.99e-05	0.000309	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CNR1—epilepsy syndrome	2.97e-05	0.000308	CbGpPWpGaD
Olmesartan—Rash—Topiramate—epilepsy syndrome	2.97e-05	0.000138	CcSEcCtD
Olmesartan—Dermatitis—Topiramate—epilepsy syndrome	2.96e-05	0.000138	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.96e-05	0.000307	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.95e-05	0.000306	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CHRM1—epilepsy syndrome	2.95e-05	0.000306	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR7—epilepsy syndrome	2.95e-05	0.000306	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDYN—epilepsy syndrome	2.95e-05	0.000306	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRM1—epilepsy syndrome	2.95e-05	0.000306	CbGpPWpGaD
Olmesartan—Headache—Topiramate—epilepsy syndrome	2.95e-05	0.000137	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.92e-05	0.000302	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR7—epilepsy syndrome	2.9e-05	0.0003	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—KCNJ11—epilepsy syndrome	2.86e-05	0.000297	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CHRM3—epilepsy syndrome	2.86e-05	0.000297	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.82e-05	0.000292	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.81e-05	0.000291	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ASAH1—epilepsy syndrome	2.81e-05	0.000291	CbGpPWpGaD
Olmesartan—Nausea—Topiramate—epilepsy syndrome	2.79e-05	0.00013	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.78e-05	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GAL—epilepsy syndrome	2.78e-05	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GFAP—epilepsy syndrome	2.78e-05	0.000287	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.78e-05	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT3—epilepsy syndrome	2.76e-05	0.000286	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CHRM3—epilepsy syndrome	2.74e-05	0.000284	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP2—epilepsy syndrome	2.74e-05	0.000284	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRM5—epilepsy syndrome	2.74e-05	0.000284	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—STXBP1—epilepsy syndrome	2.73e-05	0.000283	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AVP—epilepsy syndrome	2.69e-05	0.000278	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.67e-05	0.000276	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NT5E—epilepsy syndrome	2.66e-05	0.000276	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALAD—epilepsy syndrome	2.66e-05	0.000276	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.65e-05	0.000274	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.63e-05	0.000272	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.61e-05	0.000271	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.58e-05	0.000267	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.58e-05	0.000267	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CHRM2—epilepsy syndrome	2.58e-05	0.000267	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.57e-05	0.000266	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDH7A1—epilepsy syndrome	2.54e-05	0.000263	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CACNA1A—epilepsy syndrome	2.54e-05	0.000263	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CDC42—epilepsy syndrome	2.52e-05	0.000261	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GABBR1—epilepsy syndrome	2.51e-05	0.00026	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ST3GAL3—epilepsy syndrome	2.48e-05	0.000257	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AVP—epilepsy syndrome	2.44e-05	0.000253	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADSL—epilepsy syndrome	2.43e-05	0.000252	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRH3—epilepsy syndrome	2.41e-05	0.000249	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GLUL—epilepsy syndrome	2.39e-05	0.000247	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OPRM1—epilepsy syndrome	2.37e-05	0.000245	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CACNA1D—epilepsy syndrome	2.34e-05	0.000243	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCG2—epilepsy syndrome	2.33e-05	0.000242	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.32e-05	0.00024	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.3e-05	0.000238	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.29e-05	0.000237	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2C19—epilepsy syndrome	2.28e-05	0.000236	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP11A1—epilepsy syndrome	2.26e-05	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.25e-05	0.000232	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR3—epilepsy syndrome	2.24e-05	0.000232	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.24e-05	0.000232	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.23e-05	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TXNRD1—epilepsy syndrome	2.19e-05	0.000227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPY—epilepsy syndrome	2.18e-05	0.000226	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.18e-05	0.000226	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.18e-05	0.000226	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.16e-05	0.000223	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AQP1—epilepsy syndrome	2.13e-05	0.00022	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGT—epilepsy syndrome	2.12e-05	0.00022	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OXT—epilepsy syndrome	2.1e-05	0.000218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HSPB1—epilepsy syndrome	2.1e-05	0.000218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL2—epilepsy syndrome	2.1e-05	0.000218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRH—epilepsy syndrome	2.1e-05	0.000218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL3—epilepsy syndrome	2.1e-05	0.000218	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.09e-05	0.000216	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—epilepsy syndrome	2.08e-05	0.000215	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.05e-05	0.000212	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.04e-05	0.000212	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2D6—epilepsy syndrome	2.04e-05	0.000211	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.03e-05	0.00021	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.96e-05	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TSC1—epilepsy syndrome	1.96e-05	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTK2B—epilepsy syndrome	1.96e-05	0.000203	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.95e-05	0.000202	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADRA2A—epilepsy syndrome	1.94e-05	0.000201	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BCHE—epilepsy syndrome	1.93e-05	0.0002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGT—epilepsy syndrome	1.93e-05	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—KCNJ11—epilepsy syndrome	1.92e-05	0.000199	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CHRM3—epilepsy syndrome	1.92e-05	0.000199	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR2—epilepsy syndrome	1.9e-05	0.000197	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK2—epilepsy syndrome	1.9e-05	0.000197	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SST—epilepsy syndrome	1.9e-05	0.000197	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DUSP6—epilepsy syndrome	1.89e-05	0.000195	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.86e-05	0.000193	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLAT—epilepsy syndrome	1.85e-05	0.000192	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC2A1—epilepsy syndrome	1.85e-05	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLCB1—epilepsy syndrome	1.83e-05	0.000189	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TH—epilepsy syndrome	1.82e-05	0.000188	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.79e-05	0.000186	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.79e-05	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.79e-05	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.79e-05	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.79e-05	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.78e-05	0.000184	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.77e-05	0.000184	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.76e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUNB—epilepsy syndrome	1.76e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CNR1—epilepsy syndrome	1.76e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.75e-05	0.000181	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR7—epilepsy syndrome	1.71e-05	0.000177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.66e-05	0.000172	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT3—epilepsy syndrome	1.63e-05	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—epilepsy syndrome	1.62e-05	0.000168	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.59e-05	0.000165	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—epilepsy syndrome	1.59e-05	0.000164	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	1.57e-05	0.000162	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	1.53e-05	0.000158	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	1.52e-05	0.000157	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—epilepsy syndrome	1.52e-05	0.000157	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.51e-05	0.000156	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—S100B—epilepsy syndrome	1.51e-05	0.000156	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—epilepsy syndrome	1.5e-05	0.000155	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.49e-05	0.000155	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDC42—epilepsy syndrome	1.49e-05	0.000154	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCB1—epilepsy syndrome	1.46e-05	0.000151	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AVP—epilepsy syndrome	1.44e-05	0.000149	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.39e-05	0.000144	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.38e-05	0.000142	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	1.37e-05	0.000142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HES1—epilepsy syndrome	1.36e-05	0.000141	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPX1—epilepsy syndrome	1.35e-05	0.00014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FYN—epilepsy syndrome	1.33e-05	0.000137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.32e-05	0.000137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.32e-05	0.000137	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.31e-05	0.000135	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	1.31e-05	0.000135	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	1.3e-05	0.000135	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.27e-05	0.000132	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGF—epilepsy syndrome	1.26e-05	0.00013	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	1.24e-05	0.000128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	1.23e-05	0.000127	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—epilepsy syndrome	1.23e-05	0.000127	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TH—epilepsy syndrome	1.22e-05	0.000127	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.2e-05	0.000125	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.2e-05	0.000124	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AGT—epilepsy syndrome	1.19e-05	0.000123	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOE—epilepsy syndrome	1.16e-05	0.000121	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TSC2—epilepsy syndrome	1.14e-05	0.000118	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGT—epilepsy syndrome	1.14e-05	0.000118	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOE—epilepsy syndrome	1.12e-05	0.000115	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KDR—epilepsy syndrome	1.09e-05	0.000113	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.05e-05	0.000109	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.05e-05	0.000108	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	1.02e-05	0.000106	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—epilepsy syndrome	1.01e-05	0.000104	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—epilepsy syndrome	1e-05	0.000104	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	9.79e-06	0.000101	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	9.58e-06	9.92e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	9.37e-06	9.71e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—epilepsy syndrome	9.12e-06	9.44e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	9.1e-06	9.42e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	8.47e-06	8.77e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AGT—epilepsy syndrome	7.98e-06	8.26e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	7.97e-06	8.26e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	7.86e-06	8.14e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOE—epilepsy syndrome	7.82e-06	8.1e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	7.71e-06	7.99e-05	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.16e-06	7.41e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	7.09e-06	7.35e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	6.89e-06	7.13e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—epilepsy syndrome	6.72e-06	6.96e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	6.7e-06	6.94e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	6.5e-06	6.73e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	6.18e-06	6.4e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—epilepsy syndrome	6.12e-06	6.34e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	6.02e-06	6.23e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	5.36e-06	5.55e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	4.01e-06	4.15e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	3.84e-06	3.98e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	2.69e-06	2.79e-05	CbGpPWpGaD
